And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | May 27, 2020

Promising Data from Dermavant's Phase 2b Study of Tapinarof in Psoriasis

Patients treated with once daily tapinarof 1% demonstrated improvement in PASI75 as early as week 2, according to data published in The Journal of the American Academy of Dermatology (JAAD) and reported by drug developer Dermavant. Data...

Read More

News | May 26, 2020

FDA Approves Dupixent for Children Aged 6 to 11 Years with Moderate-to-Severe AD

The US Food and Drug Administration (FDA) gave its nod to Dupixent (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis (AD). Dupixent comes in two doses, prescribed based on weight (300 mg every four...

Read More

News | May 26, 2020

Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for AD

Arena Pharmaceuticals, Inc.  completed full enrollment of the Phase 2b ADVISE trial evaluating etrasimod, an investigational next-generation, once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator, for the...

Read More

News | May 22, 2020

Crayola Announces New "Colors of the World" Crayons To Help Advance "Skinclusion"

Crayola is launching Colors of the World crayons—24 new crayons designed to represent more than 40 global skin tones across the world. The crayon packs feature side panels that serve as color references. Each crayon is...

Read More
DermWire TV: Kysse Approved, Sunscreen Use Trends, Abbvie/Allergan Deal thumbnail
Play Button

DermWire TV: Kysse Approved, Sunscreen Use Trends, AbbVie/Allergan Deal

Series: DermWire TV | May 21, 2020

Galderma's Restylane Kysse is now FDA approved for lip augmentation and the correction of wrinkles around the upper lips in adults. Americans understand that sunscreen use is important to protect the skin, but they still don’t use SPF regularly, AAD data reveal. AbbVie has completed its acquisition of Allergan. 

Watch Video

Advertisement

The Latest News

Advertisement

View more